Invega sustenna 234 MG/1.5 ML 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57TL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,490
Award facts
- Contract value 100% obligated
- $10,489.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,489.83 to AmerisourceBergen Drug Corp for the supply of Invega Sustenna 234 mg/1.5 mL injectable medication. This non-set-aside, firm fixed-price contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract demonstrates AmerisourceBergen's capability to meet federal procurement requirements through open competition and efficiently fulfill essential pharmaceutical needs for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F57TL?
SPE2DR26F57TL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F57TL worth?
The government has obligated $10,490 on SPE2DR26F57TL.
Is contract SPE2DR26F57TL an order under another contract?
Yes. SPE2DR26F57TL is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57TL competed?
The extent of competition for SPE2DR26F57TL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award